Cerevel Therapeutics Holdings(CERE) - 2023 Q1 - Quarterly Report

Interest Income (Expense), Net | --- | --- | --- | --- | --- | |-----------------------------------------------------|-------|-----------------------|-------|---------------------| | ASSETS | | As \nMarch 31, 2023 | of | December 31, 2022 | | Current assets: | | | | | | Cash and cash equivalents | $ | 153,816 | $ | 136,521 | | Marketable securities | | 673,171 | | 755,509 | | Prepaid expenses and other current assets | | 13,795 | | 13,621 | | Total current assets | | 840,782 | | 905,651 | | Marketable secur ...